Vaccinia Ig ameliorates eczema vaccinatum in a murine model of atopic dermatitis

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1299-1301

  Oyoshi, Michiko K ^a   Ramesh, Narayanaswamy ^a   Geha, Raif S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OVALBUMIN; SODIUM CHLORIDE; VACCINIA ANTIBODY;

ATOPIC DERMATITIS; DRUG INDUCED DISEASE; ECZEMA; ECZEMA VACCINATUM; HISTOPATHOLOGY; LETTER; NONHUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; VACCINIA VIRUS;

EID: 84858284925     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.409     Document Type: Letter

References (15)

1. Ballow M (2011) The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 127:315-23
2. Boguniewicz M, Leung DY (2010) Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125:4-13
3. Combadiere B, Boissonnas A, Carcelain G et al. (2004) Distinct time effects of vaccination on long-term proliferative and IFN-gammaproducing T cell memory to smallpox in humans. J Exp Med 199:1585-93
4. Copeman PW, Banatvala JE (1971) The skin and vaccination against smallpox. Br J Dermatol 84:169-73
5. Fisher RW, Reed JL, Snoy PJ et al. (2011) Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin. Clin Vaccine Immunol 18:67-74
6. Goldstein JA, Neff JM, Lane JM et al. (1975) Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics 55:342-7
7. Hopkins RJ, Lane JM (2004) Clinical efficacy of intramuscular vaccinia immune globulin: A literature review. Clin Infect Dis 39:819-25
8. Howell MD, Gallo RL, Boguniewicz M et al. (2006) Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341-8
9. Nanning W (1962) Prophylactic effect of antivaccinia gamma-globulin against post-vaccinal encephalitis. Bull World Health Organ 27:317-24
10. Oyoshi MK, Elkhal A, Kumar L et al. (2009) Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response. Proc Natl Acad Sci USA 106:14954-9
11. Oyoshi MK, Wang JY, Geha RS (2011) Immunization with modified vaccinia virus Ankara prevents eczema vaccinatum in a murine model of atopic dermatitis. J Allergy Clin Immunol 128:890-2 e3
12. Postigo A, Martin MC, Dodding MP et al. (2009) Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-Apoptotic protein F1L synergize to suppress cell death during infection. Cell Microbiol 11: 1208-18
13. Shearer JD, Siemann L, Gerkovich M et al. (2005) Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection. Antimicrob Agents Chemother 49:2634-41
14. Tomimori Y, Kawakami Y, McCausland MM et al. (2011) Protective murine and human monoclonal antibodies against eczema vaccinatum. Antivir Ther 16:67-75
15. Xu R, Johnson AJ, Liggitt D et al. (2004) Cellular and humoral immunity against vaccinia virus infection of mice. J Immunol 172:6265-71